Literature DB >> 34798244

Acute Echocardiographic Effects of Exogenous Ketone Administration in Healthy Participants.

Senthil Selvaraj1, Ray Hu2, Mahesh K Vidula2, Supritha Dugyala3, Ann Tierney4, Bonnie Ky5, Kenneth B Margulies6, Svati H Shah7, Daniel P Kelly8, Paco E Bravo9.   

Abstract

BACKGROUND: Interest in therapeutic applications of exogenous ketones has grown significantly, spanning patients with heart failure to endurance athletes. Exogenous ketones engender significant effects on cardiac function in heart failure and provide an ergogenic benefit in athletes. The aim of this study was to assess the effects of exogenous ketones on cardiac function in healthy participants.
METHODS: In a single-arm intervention study, 20 fasting, healthy participants underwent comprehensive echocardiography (two-dimensional, Doppler, and strain) before and 30 min after weight-based oral ketone ester administration. The relationship between changes in log-transformed biomarker levels and change in absolute global longitudinal strain (GLS) was assessed using linear regression.
RESULTS: The mean age was 30 ± 7 years, 50% were women, 45% were nonwhite, and the average body mass index was 24.3 ± 3.1 kg/m2. Ketone ingestion acutely elevated β-hydroxybutyrate levels from a median of 0.13 mmol/L (interquartile range, 0.10-0.37 mmol/L) to 3.23 mmol/L (interquartile range, 2.40-4.97 mmol/L) (P < .001). After ketone ester consumption, systolic blood pressure, heart rate, biventricular function, left ventricular GLS, and left atrial (LA) strain all augmented, while systemic vascular resistance decreased. Displayed as mean change, increases in ejection fraction (3.1%; 95% CI, 2.0%-4.2%; P < .001), GLS (2.0%; 95% CI, 1.4%-2.7%; P < .001), right ventricular S' (1.1 cm/sec; 95% CI, 0.4-1.8 cm/sec; P = .004), LA reservoir strain (7%; 95% CI, 3%-12%; P = .005), and LA contractile strain (4%; 2%-6%; P = .001) were observed. During robustly achieved ketosis, change in GLS was inversely associated with change in nonesterified fatty acids (P = .019).
CONCLUSIONS: In a single-arm study, systolic blood pressure, heart rate, biventricular function, and LV and LA strain acutely augmented after ketone ester ingestion in healthy, fasting participants, similar to several effects observed in the failing heart. These data may provide supporting data for the ergogenic benefits observed in athletes and may become increasingly relevant with exogenous ketone consumption across a variety of cardiovascular and noncardiovascular applications.
Copyright © 2021 American Society of Echocardiography. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Echocardiography; Insulin; Ketone ester; Ketones; Metabolism

Mesh:

Substances:

Year:  2021        PMID: 34798244      PMCID: PMC8901445          DOI: 10.1016/j.echo.2021.10.017

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  28 in total

1.  Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography.

Authors:  Lawrence G Rudski; Wyman W Lai; Jonathan Afilalo; Lanqi Hua; Mark D Handschumacher; Krishnaswamy Chandrasekaran; Scott D Solomon; Eric K Louie; Nelson B Schiller
Journal:  J Am Soc Echocardiogr       Date:  2010-07       Impact factor: 5.251

2.  Implications of Altered Ketone Metabolism and Therapeutic Ketosis in Heart Failure.

Authors:  Senthil Selvaraj; Daniel P Kelly; Kenneth B Margulies
Journal:  Circulation       Date:  2020-06-01       Impact factor: 29.690

3.  Effect of food intake on left and right ventricular systolic tissue Doppler measurements.

Authors:  Anna Dieden; Ylva Gårdinger; Joanna Hlebowicz; Ola Björgell; Magnus Dencker
Journal:  Clin Physiol Funct Imaging       Date:  2015-05-15       Impact factor: 2.273

4.  Comprehensive quantification of fuel use by the failing and nonfailing human heart.

Authors:  Danielle Murashige; Cholsoon Jang; Michael Neinast; Jonathan J Edwards; Alexis Cowan; Matthew C Hyman; Joshua D Rabinowitz; David S Frankel; Zolt Arany
Journal:  Science       Date:  2020-10-16       Impact factor: 47.728

5.  Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.

Authors:  Pete J Cox; Tom Kirk; Tom Ashmore; Kristof Willerton; Rhys Evans; Alan Smith; Andrew J Murray; Brianna Stubbs; James West; Stewart W McLure; M Todd King; Michael S Dodd; Cameron Holloway; Stefan Neubauer; Scott Drawer; Richard L Veech; Julian L Griffin; Kieran Clarke
Journal:  Cell Metab       Date:  2016-07-27       Impact factor: 27.287

Review 6.  Metabolism of ketone bodies during exercise and training: physiological basis for exogenous supplementation.

Authors:  Mark Evans; Karl E Cogan; Brendan Egan
Journal:  J Physiol       Date:  2016-12-07       Impact factor: 5.182

7.  Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects.

Authors:  Kieran Clarke; Kirill Tchabanenko; Robert Pawlosky; Emma Carter; M Todd King; Kathy Musa-Veloso; Manki Ho; Ashley Roberts; Jeremy Robertson; Theodore B Vanitallie; Richard L Veech
Journal:  Regul Toxicol Pharmacol       Date:  2012-05-03       Impact factor: 3.271

Review 8.  Therapeutic Potential of Ketone Bodies for Patients With Cardiovascular Disease: JACC State-of-the-Art Review.

Authors:  Salva R Yurista; Cher-Rin Chong; Juan J Badimon; Daniel P Kelly; Rudolf A de Boer; B Daan Westenbrink
Journal:  J Am Coll Cardiol       Date:  2021-02-23       Impact factor: 24.094

9.  On the Metabolism of Exogenous Ketones in Humans.

Authors:  Brianna J Stubbs; Pete J Cox; Rhys D Evans; Peter Santer; Jack J Miller; Olivia K Faull; Snapper Magor-Elliott; Satoshi Hiyama; Matthew Stirling; Kieran Clarke
Journal:  Front Physiol       Date:  2017-10-30       Impact factor: 4.566

10.  The failing heart utilizes 3-hydroxybutyrate as a metabolic stress defense.

Authors:  Julie L Horton; Michael T Davidson; Clara Kurishima; Rick B Vega; Jeffery C Powers; Timothy R Matsuura; Christopher Petucci; E Douglas Lewandowski; Peter A Crawford; Deborah M Muoio; Fabio A Recchia; Daniel P Kelly
Journal:  JCI Insight       Date:  2019-02-21
View more
  3 in total

1.  Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF.

Authors:  Mikhail N Kosiborod; Svati H Shah; Senthil Selvaraj; Zhuxuan Fu; Philip Jones; Lydia C Kwee; Sheryl L Windsor; Olga Ilkayeva; Christopher B Newgard; Kenneth B Margulies; Mansoor Husain; Silvio E Inzucchi; Darren K McGuire; Bertram Pitt; Benjamin M Scirica; David E Lanfear; Michael E Nassif; Ali Javaheri; Robert J Mentz
Journal:  Circulation       Date:  2022-05-23       Impact factor: 39.918

2.  Association of Serum β-Hydroxybutyrate and Coronary Artery Disease in an Urban Chinese Population.

Authors:  Hongna Mu; Ruiyue Yang; Siming Wang; Wenduo Zhang; Xinyue Wang; Hongxia Li; Jun Dong; Wenxiang Chen; Xue Yu; Fusui Ji
Journal:  Front Nutr       Date:  2022-02-17

Review 3.  Exogenous Ketones and Lactate as a Potential Therapeutic Intervention for Brain Injury and Neurodegenerative Conditions.

Authors:  Naomi Elyse Omori; Geoffrey Hubert Woo; Latt Shahril Mansor
Journal:  Front Hum Neurosci       Date:  2022-04-28       Impact factor: 3.473

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.